We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

DYNEX

Designs and manufactures fully-automated ELISA microplate workstations, laboratory instruments and associated consuma... read more Featured Products: More products

Download Mobile App




Automated ELISA System Delivers Speed, Precision and Flexibility to Clinical Diagnostic Labs

By LabMedica International staff writers
Posted on 02 Jan 2024
Print article
Image: The Agility Integra provides ELISA automation that meets 21 CFR part 11 regulatory compliance (Photo courtesy of DYNEX)
Image: The Agility Integra provides ELISA automation that meets 21 CFR part 11 regulatory compliance (Photo courtesy of DYNEX)

A new fully automated ELISA system featuring the latest enhancements helps achieve powerful lab proficiency while ensuring the security of data to meet all the requirements of 21 CFR Part 11.

DYNEX Technologies (Chantilly, VA, USA) has unveiled the Agility Integra fully automated ELISA system that brings speed, precision, and flexibility to clinical diagnostic laboratories. This high-throughput system comes with upgraded software capabilities for powerful results that comply with FDA Regulation 21 CFR Part 11. Agility Integra’s open system takes ELISA testing to the next level, by allowing multiple immunoassays to run simultaneously. It guarantees data integrity and security with improved audit trails, chain of custody, lab information system connectivity, and secure networking.

With Agility Integra, labs can benefit from high-volume, walk-away processing of multiple assays, faster automation and continuous loading of samples, fewer manual processes and improved workflows, and increased lab efficiency and maximum output, among others. Other advantages include enhanced import and export functionality, upgraded data encryption, and optimized reporting. This latest innovation represents the next step in DYNEX’s flagship automated microplate processor and offers unique value for highly regulated laboratory environments.

DYNEX Vice President of Innovation, Rich Bahlmann, views the Agility Integra system as “a true game changer in the realm of clinical research and drug development, offering superior pipetting accuracy and state-of-the-art data protection.” Mr. Bahlmann is confident that the system “will propel clinical research and drug development initiatives forward, paving the way for groundbreaking advancements within the pharmaceutical and biotechnology field.”

Related Links:
DYNEX Technologies

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.